A Web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis

23Citations
Citations of this article
61Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background and purpose: The Evidence-Based Decision Support Tool in Multiple Sclerosis (EBDiMS) is the first Web-based prognostic calculator in multiple sclerosis (MS) capable of delivering individualized estimates of disease progression. It has recently been extended to provide long-term predictions based on the data from a large natural history cohort. Methods: We compared the predictive accuracy and consistency of EBDiMS with that of 17 neurologists highly specialized in MS. Results: We show that whilst the predictive accuracy was similar, neurologists showed a significant intra-rater and inter-rater variability. Conclusions: Because EBDiMS was consistent, it is of superior utility in a specialist setting. Further field testing of EBDiMS in non-specialist settings, and investigation of its usefulness for counselling patients in treatment decisions, is warranted. © 2012 The Author(s).

Cite

CITATION STYLE

APA

Galea, I., Lederer, C., Neuhaus, A., Muraro, P. A., Scalfari, A., Koch-Henriksen, N., … Daumer, M. (2013). A Web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis. European Journal of Neurology, 20(7), 1107–1109. https://doi.org/10.1111/ene.12016

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free